Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions

EMBO Rep. 2017 Apr;18(4):536-548. doi: 10.15252/embr.201643139. Epub 2017 Mar 6.

Abstract

The protein p53 plays a crucial role in the regulation of cellular responses to diverse stresses. Thus, a major priority in cell biology is to define the mechanisms that regulate p53 activity in response to stresses or maintain it at basal levels under normal conditions. Moreover, further investigation is required to establish whether RNA participates in regulating p53's interaction with other proteins. Here, by conducting systematic experiments, we discovered a p53 interactor-hnRNPC-that directly binds to p53, destabilizes it, and prevents its activation under normal conditions. Upon doxorubicin treatment, the lncRNA SNHG1 is retained in the nucleus through its binding with nucleolin and it competes with p53 for hnRNPC binding, which upregulates p53 levels and promotes p53-dependent apoptosis by impairing hnRNPC regulation of p53 activity. Our results indicate that a balance between lncRNA SNHG1 and hnRNPC regulates p53 activity and p53-dependent apoptosis upon doxorubicin treatment, and further indicate that a change in lncRNA subcellular localization under specific circumstances is biologically significant.

Keywords: SNHG1; doxorubicin; hnRNPC; lncRNA; p53.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Carrier Proteins / metabolism
  • Cell Line, Tumor
  • Cell Nucleus / genetics*
  • Cell Nucleus / metabolism*
  • Doxorubicin / pharmacology*
  • Heterogeneous-Nuclear Ribonucleoprotein Group C / metabolism*
  • Humans
  • Models, Biological
  • Nucleotide Motifs
  • Protein Binding
  • Protein Stability
  • RNA Transport / drug effects*
  • RNA, Long Noncoding / chemistry
  • RNA, Long Noncoding / genetics*
  • RNA, Long Noncoding / metabolism
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Carrier Proteins
  • HNRNPC protein, human
  • Heterogeneous-Nuclear Ribonucleoprotein Group C
  • RNA, Long Noncoding
  • Tumor Suppressor Protein p53
  • long non-coding RNA SNHG1, human
  • Doxorubicin